CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Grant or award Director acquired 6,027 shares (grant or award)
- 4 Grant or award Director acquired 6,027 shares (grant or award)
- 4 Grant or award Director acquired 6,027 shares (grant or award)
- 4 Open-market sale 10% owner sold 183,547 shares at an average $25.55 ($4,690,136)
- 8-K Event Shareholder vote results
- 144 Insider Sale of Securities
- 4 Open-market sale 10% owner sold 136 shares at $25.10 ($3,414)
- 10-Q Report Quarterly Report
- 4 Open-market sale 10% owner sold 198,006 shares at an average $25.53 ($5,055,851)
- 8-K Event Results of operations
- 4 Open-market sale 10% owner sold 3,075 shares at $25.30 ($77,812)
- 4 Open-market sale 10% owner sold 66,999 shares at an average $25.42 ($1,702,946)
- 4 Open-market sale 10% owner sold 311,983 shares at an average $25.76 ($8,037,394)
- 4 Open-market sale 10% owner sold 83,067 shares at an average $25.12 ($2,086,630)
- 4 Open-market sale 10% owner sold 20,089 shares at an average $25.08 ($503,893)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Grant or award Chief Executive Officer acquired 576,452 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 16 of 41 · 806 filings